Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
0.505
-0.122 (-19.44%)
At close: Nov 4, 2024, 4:00 PM
0.510
+0.005 (1.01%)
After-hours: Nov 4, 2024, 7:59 PM EST
Cyclacel Pharmaceuticals Employees
Cyclacel Pharmaceuticals had 12 employees as of December 31, 2019. The number of employees decreased by 2 or -14.29% compared to the previous year.
Employees
12
Change (1Y)
-2
Growth (1Y)
-14.29%
Revenue / Employee
$6,667
Profits / Employee
-$1,467,167
Market Cap
996.97K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
TC Biopharm (Holdings) | 41 |
LogicMark | 27 |
Elevai Labs | 18 |
Catheter Precision | 14 |
Revelation Biosciences | 9 |
PainReform | 7 |
60 Degrees Pharmaceuticals | 3 |
SciSparc | 3 |
CYCC News
- 11 days ago - Cyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard Rule - GlobeNewsWire
- 12 days ago - Cyclacel Pharmaceuticals Reports New Clinical Data from Ongoing, Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium - GlobeNewsWire
- 26 days ago - Cyclacel Pharmaceuticals to Present New Clinical Data From Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium - GlobeNewsWire
- 5 weeks ago - Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study - GlobeNewsWire
- 2 months ago - Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter - GlobeNewsWire
- 2 months ago - Cyclacel Pharmaceuticals, Inc. (CYCC) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Cyclacel Pharmaceuticals to Release Second Quarter 2024 Financial Results - GlobeNewsWire